Women and babies are dying from inertia: a collaborative framework for obstetrical drug development is urgently needed
Research article
[키워드] absence
addition
Adverse reactions
approval
cause
clinical development
clinical trials with pregnant women
clinician
Complication
complications
develop
drug
drug candidate
Drug development
drug therapy
effective
facilitate
fetal
fetal growth restriction
Guidance
Health
Inclusion
Infants
legislative framework
limit
morbidity
Mortality
obstetrical syndromes
obstetrics
pathophysiology
patients
pharmaceutical treatment
placental transfer
preclinical studies
preeclampsia
pregnancies
Pregnancy
pregnancy complications
pregnant women
prenatal
preterm delivery
preterm labor
preterm premature rupture of membranes
reduced
Regulatory
Research
research and development
Safe
small for gestational age
solution
subject
syndrome
Therapies
therapy
translational
Treatment
treatment during pregnancy
trials
unmet need
women
[DOI] 10.1016/j.ajog.2021.03.024 [Article Type] Research article
[DOI] 10.1016/j.ajog.2021.03.024 [Article Type] Research article